ArticleSurgery2026

Does neoadjuvant systemic therapy in clinical T1-2 N0 human epidermal growth factor receptor 2-positive breast cancer increase the extent of axillary surgery?

Christine C Rogers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.